卡佩奇他可能加速动脉样硬化,并导致左侧主干中急性心肌梗塞
Tetsuo Yamanaka1, Tatsuhiko Ishihara2, Koutarou Miyata3
1Cardiology, Tokyo Teishin Hospital, Tokyo, JPN.
Cureus
|June 28, 2023
概括
这项案例研究表明,capecitabine化疗可能有助于动脉样硬化进展. 一名59岁的男子在接受结肠癌治疗后经历了急性心肌梗塞.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 一名59岁的男性有史以来的西格结肠癌,接受了capecitabine治疗,患上了急性心肌梗塞.
- 该患者具有最小的传统心血管风险因素,只注意到失脂症,这被认为不太可能导致显著的动脉样硬化.
研究的目的:
- 调查capecitabine管理与急性心肌梗塞发展之间的潜在关联.
- 在临床案例中探索capecitabine在加速动脉样硬化过程中的作用.
主要方法:
- 病例报告详细介绍患者的病史,治疗和临床表现.
- 临床评估和审查患者的风险因素和治疗时间表.
主要成果:
- 患者在完成辅助卡佩奇他化疗后大约一年发生了急性心肌梗塞.
- 皮肤冠状动脉干预用于治疗心肌梗塞.
结论:
- 据推测,capecitabine的使用在这个病人身上有助于动脉样硬化的进展.
- 这一案例突出了capecitabine治疗的潜在,尽管很少见的心血管不良影响,这需要进一步调查.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
22
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22
Peripheral Artery Disease I: Introduction
11
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
11
Imaging Studies for Cardiovascular System V: CT
45
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
45
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
574
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
574
Coronary Artery Disease III: Clinical Manifestations
14
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
14
Acute Coronary Syndrome I: Introduction
33
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33


